Armata Pharmaceuticals In... (ARMP)
The price, the headline numbers and the latest news, in one place.
Armata Pharmaceuticals Inc. (ARMP) Stock Price, Analysis & Data
| Bid | 4.96 |
| Market Cap | 189.63M |
| Revenue (ttm) | 5.54M |
| Net Income (ttm) | -192.18M |
| 1.33 | |
| -5.29 | |
| n/a | |
| -3.25 | |
| P/B (ttm) | -0.82 |
| P/S (ttm) | 34.21 |
| Earnings Date | Nov 11, 2026 |
| Ask | 4.99 |
| Volume | 105,497 |
| Avg. Volume (20D) | 151,704 |
| Open | 4.42 |
| Previous Close | 4.42 |
| Day's Range | 4.46 - 5.10 |
| 52-Week Range | 2.40 - 16.34 |
| Analyst | Strong Buy |
| Price Target | 17.5 (243.14%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ARMP
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Ange...
Financial Performance
In 2025, Armata Pharmaceuticals's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -173.8M, an increase of 818.79%.
Financial StatementsAnalyst Forecast
According to 2 analyst ratings, the average rating for ARMP stock is "Strong Buy". The 12-month stock price forecast is 17.5, which is upside of 243.14% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of 1.2 exceeds estimates by 1.64, with 513.79% YoY growth.
Analysts project revenue of ... Upgrade
